Titles of Articles with Relevance to Dermatopathology as published in the American Journal of Surgical Pathology (January-October 2005)

Benign Epithelioid Peripheral Nerve Sheath Tumors of the Soft Tissues

Mucoepidermoid Carcinoma of the Skin: A Distinct Entity From Adenosquamous Carcinoma: A Case Study With a Review of the Literature.

Superficial Low-grade Fibromyxoid Sarcoma (Evans Tumor): A Clinicopathologic Analysis of 19 Cases With a Unique Observation in the Pediatric Population.

Virus-Associated Trichodysplasia Spinulosa.

Vulvar Trichogenic Tumors: A Comparative Study With Vulvar Basal Cell Carcinoma

Histopathologic Features of Early (Patch) Lesions of Mycosis Fungoides: A Morphologic Study on 745 Biopsy Specimens From 427 Patients.

Mucinous Carcinoma of the Skin, Primary, and Secondary: A Clinicopathologic Study of 63 Cases With Emphasis on the Morphologic Spectrum of Primary Cutaneous Forms: Homologies With Mucinous Lesions in the Breast.

Soft Tissue Perineurioma: Clinicopathologic Analysis of 81 Cases Including Those With Atypical Histologic Features.

Radiation-Associated Cutaneous Atypical Vascular Lesions and Angiosarcoma: Clinicopathologic Analysis of 42 Cases.

Analysis of Mutations in B-RAF, N-RAS, and H-RAS Genes in the Differential Diagnosis of Spitz Nevus and Spitzoid Melanoma.

Genomic Analysis of Blue Nevi and Related Dermal Melanocytic Proliferations.


Issues in Dermatopathology

Are Dermatologists Qualified to Read Their Own Biopsy Slides?

Dermatologist does not equal Dermatopathologist: No place in a profession for pretenders (A. Bernard Ackerman, M.D.)

The reason that dermatologists should not send all their slides to dermatopathologists is a scope of practice argument, not an ethical argument (Ronald Moy, M.D.)

Collegiality and dermatology (Richard Gordon Glogau, M.D.)

The whys and wherefores of who reads dermatopathology slides (Jane M. Grant-Kels, M.D.)

In the October 2005 issue of the Journal of American Academy of Dermatology, four esteemed dermatologists share their views on the issue of dermatologists interpreting skin biopsies performed upon their patients. Dr. Bernard Ackerman, director emeritus of the Ackerman Academy of Dermatopathology, leads the salvo with a strongly worded statement emphatically declaring that "self-referral of a professional (a dermatologist) to an amateur (a self-styled dermatopathologist) calls seriously into question the authenticity of professionalism."

Dr. Ackerman avers that the real motive for dermatologists reading their own slides is neither altruistic nor academic but to their own self-interests and financial gain.

The next three editorials, by Drs. Moy, Glogau, and Grant-Kels, rebut various points put forth by Dr. Ackerman. Each of their editorials make fascinating reading and propose equally valid points.

I have no desire to take any sides in these heated discussions...sorry to disappoint you! Is there financial gain? Of course, when is it not? Is it a scope of practice argument? In some cases, yes. Are there dermatologists qualified to read out their own slides? In answer to this, I will share my experiences with this topic. A few months ago, one of my dermatologist clients who does read her own slides and also sends me many slide consults asked me, "Do you think dermatologists should read their own slides?" I answered her honestly and I give this same answer to any dermatologist who asks.

I truly believe that dermatologists are qualified to read out their own biopsy slides. My question to dermatologists is, Why would you want to do this?

I acknowledge all of the issues that were discussed in the articles above. Perhaps I have a naive view of the world but I think practicing clinical dermatology is enough of a challenge. Why would you want to take on the additional medico legal burden of missing a subtle malignancy? Should you review the slides on all of your cases? Absolutely! But the unanswerable question is, How do you know when you don't know? A corollary to this is you can only name what you recognize. We all face this dilemma but clearly someone who has been in practice for a longer period of time is more keenly aware of their limitations than someone fresh out of training or only reviews three or four cases a day.

I spend over 8 hours a day reading biopsies. I review over 20 journals a month (dermatology and pathology journals). At least two of these (American Journal of Dermatopathology and Journal of Cutaneous Pathology) are focused exclusively on dermatopathology. If I only read the clinical dermatology journals and these two latter journals, I would still miss a great deal of the dermatopathology literature. Look at the left hand column of this web page; I have listed the titles of articles with relevance to dermatopathology, all published during the past year in the American Journal of Surgical Pathology, a must-read journal for surgical and general pathologists. Even missing a few of these would leave me sorely lacking in dermatopathology knowledge...and this is only one journal title. As I perused my other pathology journals, I quickly counted over 40 titles of articles with similar relevance to dermatopathology, all published within this past year. This is one reason I use this forum as a means to keep my pathology and dermatology colleagues current on these key articles.

Every dermatologist must ask themselves whether they apply the same high standards to keeping up with dermatopathology as they do in keeping up with the latest therapeutic options for dermatologic conditions.

It is gratifying to read an article describing a new disease entity and then using that knowledge shortly thereafter to make the diagnosis. Such was the setting for an earlier case of Pigmented Paget's Disease of the Nipple which I first presented on this website. The article describing this unusual disease entity came out 3 weeks prior to my receiving a biopsy of this same condition. Even the pathologists who later reviewed this case at a tumor board at a major teaching university in Los Angeles were unfamiliar with the entity. I submit this example not to boast but rather to stress that I am continually humbled by the immense amount of information that must be digested by anyone practicing this craft.

I have worked with dermatologists who read their own slides, dermatologists who are both board-certified in dermatopathology and who are not. I also work with pathologists who see a high volume of skin biopsies and are not board certified in dermatopathology, and, of course, pathologists who are board-certified in dermatopathology. In all of these practice settings, I can confidently state that if these individuals see a large volume of dermatopathology and keep current with conferences and the dermatopathology literature, their diagnostic skills are excellent. The key is IF. The aforementioned individuals who are excellent do indeed keep current with their skills, an admirable and arduous task.

These same high standards must apply to every specialty in medicine. I bemoan the competition and turf battles that have arisen between pathologists and dermatologists and other specialists. Yet, this is the current state of our practice and adapt we must.

In summary, I believe that dermatologists are definitely qualified to read their own biopsy slides. It is my sincere wish that they approach this aspect of their practice with the same fervor and enthusiasm that they apply to the rest of their practice.

When you have reviewed these articles and discussion, please comment by email which I will post anonymously.

Submitted by Paul K. Shitabata, M.D.

Previous Issues in Dermatopathology

Additional References:

Extent of Dermatopathology Education


I didnt realize how heated this topic was. Although very entertaining and dramatic, it was disappointing to see professionals in a common field  throw such sharp daggers at each other. With colleagues like that who needs enemies. No wonder why physicians have a hard time sticking together. Dr. Ackerman painted such an ugly picture of dermatologists' intentions and it seems likely he caused more unrest than solve any issue with his article. I appreciated Dr. Richard Gordon Glogau's argument most since he gave credit to both the dermatologist and dermatopathologist and likened the relationship between them to that of a cardiologist and interventionalist in which more serious cases are reffered to higher level specialists. Your argument of "how do you know when you don't know", is a risk that dermatologist who read their own slides must have to take seriously  and as you mentioned must mantain their level of competency by staying up to date in dermatopathology, especially within the realm of what they are willing to read themselves and not refer to a specialist. It's likely, though, that my opinions may change after a few years of training since my level in dermatology and especially dermatopathology is less than novice.

Thanks for posting Dr. Ackerman's letter and the three subsequent replies. I particularly liked your angle on this issue too. You should consider submitting your letter. I know some excellent dermatologists who don't read their own slides, and they agree with your statement completely. Why should they risk it, like you said. In fact, the dermatologists who do not read their own slides tend to insist that their cases are only read by dermatopathologists, and not regular pathologists. So I think this argument could apply to the many pathologists who are not board-certified in dermpath but who are reading skin biopsies everyday, like myself. Maybe regular pathologists should also not be reading skin biopsies! I think I am fairly competent in reading skin biopsies on my own, but I know I wouldn't do it if you were not around for me to show cases to on a regular basis. PS. Bernie Ackerman is the only person who can write like that and still be considered sane.


First Posted on October 21, 2005

Send Emails to Webmaster at DermpathMD
Read the Medical Disclaimer